If you have a potential patient who may meet the criteria for a clinical trial, we encourage you to contact our Clinical Research Manager.
Name: Kristin Mund
Email: [email protected]
| NCT02921789 7163-CL-3201 | “A Phase 2a, Randomized, Open-Label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients” |
| NCT02548351 747-303 REGENERATE | “A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis” |
| NCT02770716 MNK19013058 | “A Multi-Center, Randomized, Placebo Controlled, Double-Blind Study to Confirm Efficacy and Safety of Terlipressin in Subjects With Hepatorenal Syndrome Type 1 (The CONFIRM Study)” |
| NCT03384875 2017-001 REFRESH II Trial | “CytoSorb® Reduction of FREe Hemoglobin/Acute Kidney Injury (AKI) During Cardiac Surgery (REFRESH II Trial)” |